Improving respectful maternity care through group antenatal care: findings from a cluster randomized controlled trial.
Journal
Research square
Titre abrégé: Res Sq
Pays: United States
ID NLM: 101768035
Informations de publication
Date de publication:
18 Dec 2023
18 Dec 2023
Historique:
pubmed:
10
1
2024
medline:
10
1
2024
entrez:
10
1
2024
Statut:
epublish
Résumé
Disrespect and patient mistreatment are identified as barriers to care-seeking and low uptake of facility-based deliveries. These mitigating factors have led to slow progress in the achievement of maternal and child health targets, especially in Ghana. Group antenatal care, as an alternative to individual antenatal was implemented to explore the impact on outcomes, including mothers' perception of respectful care. A cluster randomized controlled trial was conducted in 14 health facilities across four districts in the Easter Region of Ghana. These facilities were randomized to intervention or control using a matched pair. Data was collected at several timepoints: enrollment (Time 0), 34 weeks gestation to 3 weeks post-delivery (Time 1), 6 to 12 weeks post-delivery (Time 2), 5 to 8 months post-delivery (Time 3), and 11 to 14 months post-delivery (Time 4). Questions related to respectful care were asked at Time 2, while a focus group discussion (FGDs) was conducted as part of a process evaluation to examine participants' experiences about respectful maternity care. The findings from the intervention group indicate that participants perceived higher levels of respect in comparison to the control group. Privacy and con dentiality were maintained. They believed they had been provided with adequate information, education, and counseling, empowering them to make informed decisions. Participants perceived a shortened waiting time and reduced discrimination in care provision. Generally, there were higher levels of satisfaction with antenatal care. The provision of respectful maternity care, which is essential to increasing healthcare utilization, has been demonstrated to correlate positively with group antenatal care.
Sections du résumé
Background
UNASSIGNED
Disrespect and patient mistreatment are identified as barriers to care-seeking and low uptake of facility-based deliveries. These mitigating factors have led to slow progress in the achievement of maternal and child health targets, especially in Ghana. Group antenatal care, as an alternative to individual antenatal was implemented to explore the impact on outcomes, including mothers' perception of respectful care.
Methods
UNASSIGNED
A cluster randomized controlled trial was conducted in 14 health facilities across four districts in the Easter Region of Ghana. These facilities were randomized to intervention or control using a matched pair. Data was collected at several timepoints: enrollment (Time 0), 34 weeks gestation to 3 weeks post-delivery (Time 1), 6 to 12 weeks post-delivery (Time 2), 5 to 8 months post-delivery (Time 3), and 11 to 14 months post-delivery (Time 4). Questions related to respectful care were asked at Time 2, while a focus group discussion (FGDs) was conducted as part of a process evaluation to examine participants' experiences about respectful maternity care.
Results
UNASSIGNED
The findings from the intervention group indicate that participants perceived higher levels of respect in comparison to the control group. Privacy and con dentiality were maintained. They believed they had been provided with adequate information, education, and counseling, empowering them to make informed decisions. Participants perceived a shortened waiting time and reduced discrimination in care provision. Generally, there were higher levels of satisfaction with antenatal care.
Conclusion
UNASSIGNED
The provision of respectful maternity care, which is essential to increasing healthcare utilization, has been demonstrated to correlate positively with group antenatal care.
Identifiants
pubmed: 38196651
doi: 10.21203/rs.3.rs-3682833/v1
pmc: PMC10775374
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NICHD NIH HHS
ID : R01 HD096277
Pays : United States
Déclaration de conflit d'intérêts
Additional Declarations: No competing interests reported. Competing Interests The authors declare that they have no competing interests.
Références
J Am Med Inform Assoc. 2016 Jan;23(1):94-104
pubmed: 26510878
BMC Pregnancy Childbirth. 2020 Jan 6;20(1):15
pubmed: 31906875
J Midwifery Womens Health. 2004 May-Jun;49(3):263-5
pubmed: 15134681
BMC Pregnancy Childbirth. 2023 May 1;23(1):305
pubmed: 37127582
Gates Open Res. 2018 Nov 5;2:56
pubmed: 30706056
PLoS Med. 2015 Jun 30;12(6):e1001847; discussion e1001847
pubmed: 26126110
BJOG. 2018 Jul;125(8):932-942
pubmed: 29117644
Lancet Glob Health. 2019 Jan;7(1):e96-e109
pubmed: 30554766
BMC Med Ethics. 2023 Oct 4;24(1):76
pubmed: 37794351
Gates Open Res. 2019 Sep 27;3:1548
pubmed: 31656954
PLoS One. 2020 Dec 11;15(12):e0242909
pubmed: 33306689
J Am Board Fam Pract. 2002 Jan-Feb;15(1):25-38
pubmed: 11841136
J Midwifery Womens Health. 2020 Sep;65(5):694-699
pubmed: 33010115
Reprod Health. 2019 Jul 25;16(1):116
pubmed: 31345239
J Gen Intern Med. 2007 May;22(5):692-5
pubmed: 17443381
Reprod Health. 2014 Sep 19;11(1):71
pubmed: 25238684
BJOG. 2016 Apr;123(5):671-4
pubmed: 26628382
Reprod Health. 2019 Jun 27;16(1):90
pubmed: 31248425
BMC Pregnancy Childbirth. 2022 Jan 22;22(1):59
pubmed: 35062909
PLoS One. 2019 Oct 2;14(10):e0222177
pubmed: 31577797
Reprod Health. 2018 Mar 5;15(1):41
pubmed: 29506559
Biomed Res Int. 2020 Oct 23;2020:8186070
pubmed: 33150181
Reprod Health. 2020 Aug 24;17(1):129
pubmed: 32831100
Lancet. 2016 Oct 29;388(10056):2176-2192
pubmed: 27642019
Best Pract Res Clin Obstet Gynaecol. 2020 Aug;67:113-126
pubmed: 32245630
Midwifery. 2021 Mar;94:102904
pubmed: 33341537
PLoS One. 2023 Nov 7;18(11):e0291855
pubmed: 37934750
Reprod Health. 2020 Jul 2;17(1):103
pubmed: 32615999
Reprod Health Matters. 2018;26(53):1-5
pubmed: 30293528
Int J Gynaecol Obstet. 2021 Mar;152(3):285-287
pubmed: 32672372
J Obstet Gynecol Neonatal Nurs. 2022 Mar;51(2):e3-e54
pubmed: 35101344
Reprod Health Matters. 2018;26(53):70-87
pubmed: 30152268
Reprod Health. 2018 Mar 5;15(1):38
pubmed: 29506531
JMIR Res Protoc. 2022 Sep 9;11(9):e40828
pubmed: 36083608